Webinar Date: April 29, 11:00 AM EST
Bioanalysis has become the key part of the PK/PD characterization in drug discovery and during various stages of drug development. Bioanalysis is defined as the quantitative measurement of analytes in biological matrices, including tissue, blood, serum, urine or other body fluids. Bioanalytical method validation and regulated bioanalysis are an integral part of a drug development program.
During the webinar, Kevin Cramer, Chief Scientist of Sapio Sciences, will discuss how Exemplar Seamless ELN/LIMS provides a modern and comprehensive solution to managing your entire BA pipeline.
This webinar is offered for free. Register now to receive details.